Ditchcarbon
  • Contact
  1. Organizations
  2. OPKO Biologics
Public Profile
Pharmaceutical Preparation Manufacturing
IL
updated a month ago

OPKO Biologics Sustainability Profile

Company website

OPKO Biologics, a subsidiary of OPKO Health, Inc., is a prominent player in the biotechnology industry, headquartered in Illinois. Founded in 2007, the company has made significant strides in the development of innovative biologic therapies, particularly in the fields of protein therapeutics and drug delivery systems. With a focus on advanced biologics, OPKO Biologics offers unique products that leverage proprietary technologies to enhance therapeutic efficacy. The company is recognised for its commitment to research and development, positioning itself as a leader in the biopharmaceutical sector. Notable achievements include successful collaborations and advancements in drug formulation, which have solidified its reputation in the market. As OPKO Biologics continues to expand its operational reach, it remains dedicated to improving patient outcomes through cutting-edge biotechnological solutions.

DitchCarbon Score

How does OPKO Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

OPKO Biologics's score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Let us know if this data was useful to you

OPKO Biologics's reported carbon emissions

OPKO Biologics, headquartered in Illinois (IL), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of OPKO Health, Inc., which may influence its climate commitments and emissions reporting. As of now, OPKO Biologics has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data, it is important to note that OPKO Biologics' climate commitments may be informed by broader initiatives from its parent company, OPKO Health, Inc. However, specific details regarding these initiatives or any cascading emissions data from OPKO Health, Inc. have not been provided. In summary, OPKO Biologics is currently without specific emissions data or reduction targets, indicating a potential area for future development in their climate strategy.

How Carbon Intensive is OPKO Biologics's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OPKO Biologics's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is OPKO Biologics's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OPKO Biologics is in IL, which has a low grid carbon intensity relative to other regions.

OPKO Biologics's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

OPKO Biologics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare OPKO Biologics's Emissions with Industry Peers

Nautilus Biotech S.A.

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy